Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

KISS Study: A Phase II Study of Dasatinib Followed by Imatinib in Newly Diagnosed, Previously Untreated Patients With Chronic Phase CML

NCT03193281 is registered in ClinicalTrials.gov with University of Auckland, New Zealand as lead sponsor.

NCT NCT03193281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03193281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
KISS Study: A Phase II Study of Dasatinib Followed by Imatinib in Newly Diagnosed, Previously Untreated Patients With Chronic Phase CML
Lead sponsor
University of Auckland, New Zealand
Phase
Phase 2
Overall status
Unknown status
Start date
July 17, 2017
Completion date
December 31, 2025
Enrollment
91 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia